2011
Nephrogenic Systemic Fibrosis and Gadolinium-Based Contrast Agents
Abu-Alfa AK. Nephrogenic Systemic Fibrosis and Gadolinium-Based Contrast Agents. Advances In Kidney Disease And Health 2011, 18: 188-198. PMID: 21531325, DOI: 10.1053/j.ackd.2011.03.001.Peer-Reviewed Original ResearchConceptsAcute kidney injuryNephrogenic systemic fibrosisGadolinium-based contrast agentsCKD stage 4Immediate hemodialysisSystemic fibrosisAdministration of GBCAsCare of patientsStage 4Needs of patientsMajority of casesKidney injuryDialysis initiationPeritoneal dialysisSignificant morbidityKidney diseaseCurrent recommendationsHigh riskContrast agentsLower riskRisk differencePatientsDrug AdministrationHemodialysisIndividualized assessment
2002
Hemodynamics in patients with intradialytic hypotension treated with cool dialysate or midodrine
Hoeben H, Abu-Alfa AK, Mahnensmith R, Perazella MA. Hemodynamics in patients with intradialytic hypotension treated with cool dialysate or midodrine. American Journal Of Kidney Diseases 2002, 39: 102-107. PMID: 11774108, DOI: 10.1053/ajkd.2002.29887.Peer-Reviewed Original ResearchConceptsPeripheral vascular resistanceCentral blood volumeDialysis-associated hypotensionCardiac outputIntradialytic hypotensionIntradialytic hemodynamicsCool dialysateEnd-stage renal disease populationTermination of hemodialysisInitiation of hemodialysisMean arterial pressureRenal disease populationUltrasound dilution techniqueVascular resistanceHemodynamic stabilityArterial pressureBlood pressureUltrafiltration volumeDisease populationHypotensionBlood volumePatientsMidodrineHemodialysisHemodynamics